0001104659-23-004642.txt : 20230118
0001104659-23-004642.hdr.sgml : 20230118
20230118170155
ACCESSION NUMBER: 0001104659-23-004642
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230113
FILED AS OF DATE: 20230118
DATE AS OF CHANGE: 20230118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Raphael Erez
CENTRAL INDEX KEY: 0001668046
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37704
FILM NUMBER: 23535042
MAIL ADDRESS:
STREET 1: 9 HALAMISH STREET
STREET 2: CAESAREA INDUSTRIAL PARK
CITY: CAESAREA
STATE: L3
ZIP: 38900
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DarioHealth Corp.
CENTRAL INDEX KEY: 0001533998
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452973162
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18 W 18TH ST., 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 646.665.4667
MAIL ADDRESS:
STREET 1: 18 W 18TH ST., 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
FORMER COMPANY:
FORMER CONFORMED NAME: LabStyle Innovations Corp.
DATE OF NAME CHANGE: 20111101
4
1
tm233645-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-01-13
0
0001533998
DarioHealth Corp.
DRIO
0001668046
Raphael Erez
18 W. 18TH ST, 5TH FLOOR
NEW YORK
NY
10011
1
1
0
0
Chief Executive Officer
Common Stock
2023-01-13
4
S
0
1200
6.2075
D
1112059
D
Common Stock
37876
I
By Dicilyon Consulting and Investment Ltd.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.20 to $6.23, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.
/s/ Erez Raphael
2023-01-18